AC
IDYA icon

Athanor Capital’s IDEAYA Biosciences IDYA Stock Holding History

Athanor Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,594
Closed -$260K – 926
2020
Q4 		$260K Buy
18,594
+253
+1% +$3.43K 0.01% 600
2020
Q3 		$230K Buy
18,341
+2,999
+20% +$37.1K 0.01% 471
2020
Q2 		$218K Buy
+15,342
New +$121K 0.01% 481

Other funds holding IDYA

CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Athanor Capital's IDYA Position: Q1 2021 in Review

Athanor Capital sold out of IDEAYA Biosciences (IDYA) in Q1 2021, closing a stake of 18,594 shares — an estimated $260K sold.

Athanor Capital first reported a position in IDYA in Q2 2020 and held it in 3 quarters. The position peaked at $260K in Q4 2020. 89 funds tracked by Wall St. Rank hold IDYA as of Q1 2021.

  • Athanor Capital reported no remaining IDEAYA Biosciences position as of Q1 2021 after selling out during the quarter.
  • Athanor Capital sold 18,594 IDEAYA Biosciences shares in Q1 2021, an estimated $260K.
  • Athanor Capital first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 3 quarters.
  • Athanor Capital's IDEAYA Biosciences position peaked at $260K in Q4 2020.
  • 89 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.